News Search

07.17.2019 | Products

Government of Quebec Now Covers a More Effective Emergency Contraceptive Pill

TORONTO, July 11, 2019 /CNW/ - Allergan Inc., announced today that ella®, a highly effective emergency oral contraceptive, is now covered by the Régie de L'assurance Maladie du Québec (RAMQ). ella® is reimbursed and available at pharmacies across the province, for the prevention of pregnancy when taken within five days (120 hours) of unprotected intercourse or a known or suspected contraceptive failure.1
ella® dispels the notion of the morning after pill. It can be given up to 5 days after intercourse2 and it is two times more effective than other oral options in the market when taken within the first 24 hours.2/3

"Today's RAMQ announcement is a great development for women in our province," says Dr. Fabien Simard, outgoing President of the Association of Obstetricians and Gynecologists of Quebec (AOGQ). "Now all Quebec women seeking emergency contraception have a wide and effective range of therapeutic options available to them."

Canadian women spend a significant portion of their lives at risk of an unintended pregnancy.3 Emergency contraceptive pills are used by women to prevent pregnancy after intercourse but before implantation. 

"It's important for women to be aware of treatments best suited for their individual needs," says Ema Ferreira, Pharmacist, CHU Ste-Justine, Vice Dean, Faculty of Pharmacy, University of Montreal. "Having greater access is a positive step forward for women's health in Quebec."

ella® Facts

  • ella® (ulipristal acetate 30 mg) for emergency contraception is more effective than levonorgestrel emergency contraception.2/3
  • ella® can be taken up to 5 days after unprotected intercourse.2/3
  • ella® is also effective for patients with a higher body mass index(BMI)*.4
  • ella® is a simple, one-pill dose.1
*Note: Not evaluated in women with BMI over 35 kg/m2.

"We applaud the Government of Quebec's decision to support women's reproductive rights," says Peter Dale, Chief, Women's Health Department at Allergan Inc. "For women who are looking for options to reduce their risk of pregnancy after unprotected intercourse, ella® is more effective and as of today, more widely accessible."

1 ella™ (ulipristal acetate) Product Monograph. Allergan, 2018.
2 Glasier et al. Lancet. 2010. Feb 13;375 (9714):555-62.
3 SOGC. J Obstet. Gynaecol Can. 2015 Oct; 37 (10 Suppl) S5-S11.
4 Glasier et al. Contraception, 2011 Feb 11; 84:363-367.